State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center. The research team of Prof. Wanliang Lu has developed dual-responsive nanoparticles for enhanced drug delivery in breast cancer chemotherapy[J]. Journal of Chinese Pharmaceutical Sciences, 2025, 34(1): 83-83.
>
>